AU2003281176A1 - Medicinal composition for mitigating blood lipid or lowering blood homocystein - Google Patents
Medicinal composition for mitigating blood lipid or lowering blood homocysteinInfo
- Publication number
- AU2003281176A1 AU2003281176A1 AU2003281176A AU2003281176A AU2003281176A1 AU 2003281176 A1 AU2003281176 A1 AU 2003281176A1 AU 2003281176 A AU2003281176 A AU 2003281176A AU 2003281176 A AU2003281176 A AU 2003281176A AU 2003281176 A1 AU2003281176 A1 AU 2003281176A1
- Authority
- AU
- Australia
- Prior art keywords
- blood
- homocystein
- mitigating
- medicinal composition
- lowering
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000008280 blood Substances 0.000 title 2
- 210000004369 blood Anatomy 0.000 title 2
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 title 1
- 150000002632 lipids Chemical class 0.000 title 1
- 230000000116 mitigating effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002202121 | 2002-07-11 | ||
| JP2002-202121 | 2002-07-11 | ||
| JP2002343586 | 2002-11-27 | ||
| JP2002-343586 | 2002-11-27 | ||
| PCT/JP2003/008674 WO2004006919A1 (en) | 2002-07-11 | 2003-07-08 | Medicinal composition for mitigating blood lipid or lowering blood homocystein |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003281176A1 true AU2003281176A1 (en) | 2004-02-02 |
Family
ID=30117429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003281176A Abandoned AU2003281176A1 (en) | 2002-07-11 | 2003-07-08 | Medicinal composition for mitigating blood lipid or lowering blood homocystein |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JP2010077162A (en) |
| CN (1) | CN100341509C (en) |
| AU (1) | AU2003281176A1 (en) |
| CA (1) | CA2492781A1 (en) |
| TW (1) | TWI302457B (en) |
| WO (1) | WO2004006919A1 (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004305154A1 (en) * | 2003-12-23 | 2005-07-07 | Medicure International Inc. | Combination therapies employing a composition comprising a HMG CoA reductase inhibitor and a vitamin B6 related compound |
| JP4949661B2 (en) * | 2004-09-21 | 2012-06-13 | 第一三共株式会社 | Pharmaceutical composition containing HMG-CoA reductase inhibitor and glutathione |
| TW200612896A (en) * | 2004-09-21 | 2006-05-01 | Sankyo Co | Pharmaceutical compositions containing with HMG-CoA reductase inhibitor and glutathione |
| PL2018153T3 (en) | 2006-04-26 | 2012-09-28 | Rosemont Pharmaceuticals Ltd | Liquid oral compositions |
| JPWO2015060317A1 (en) * | 2013-10-22 | 2017-04-06 | 長谷川 亨 | Testing method for neurodegenerative diseases |
| JP6009050B1 (en) * | 2015-08-21 | 2016-10-19 | 国立大学法人東北大学 | Reducing or preventing sickness or hangover caused by drinking |
| WO2020046132A1 (en) | 2018-08-31 | 2020-03-05 | Leiden University | Pharmacological chaperones for enzyme treatment therapy |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06192105A (en) * | 1992-09-14 | 1994-07-12 | Vesta Medicines Pty Ltd | Medical preparation for lowering level of homocysteine |
| EP0904082A4 (en) * | 1996-04-17 | 2001-09-26 | Merck & Co Inc | ASSOCIATION THERAPY TO REDUCE THE RISKS OF CARDIOVASCULAR DISEASE |
| CA2306646A1 (en) * | 1997-10-22 | 1999-04-29 | Merck & Co., Inc. | Combination therapy for reducing the risks associated with cardio- and cerebrovascular disease |
| GB9916536D0 (en) * | 1999-07-14 | 1999-09-15 | Scarista Limited | Nutritional or pharmaceutical compositions |
| EP1339429A4 (en) * | 2000-11-29 | 2007-03-14 | Smithkline Beecham Corp | Composition containing statins and calcium for improved cardiovascular health |
| US6669955B2 (en) * | 2001-08-28 | 2003-12-30 | Longwood Pharmaceutical Research, Inc. | Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
-
2003
- 2003-07-08 CA CA002492781A patent/CA2492781A1/en not_active Abandoned
- 2003-07-08 WO PCT/JP2003/008674 patent/WO2004006919A1/en not_active Ceased
- 2003-07-08 CN CNB038216418A patent/CN100341509C/en not_active Expired - Fee Related
- 2003-07-08 AU AU2003281176A patent/AU2003281176A1/en not_active Abandoned
- 2003-07-10 TW TW092118805A patent/TWI302457B/en not_active IP Right Cessation
-
2010
- 2010-01-08 JP JP2010002651A patent/JP2010077162A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| HK1077232A1 (en) | 2006-02-10 |
| TW200403053A (en) | 2004-03-01 |
| WO2004006919A1 (en) | 2004-01-22 |
| TWI302457B (en) | 2008-11-01 |
| CN100341509C (en) | 2007-10-10 |
| CN1681499A (en) | 2005-10-12 |
| JP2010077162A (en) | 2010-04-08 |
| CA2492781A1 (en) | 2004-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003254553A1 (en) | Medical implant | |
| AU2003253106A1 (en) | Medical implant | |
| AU2003232258A1 (en) | Medical implant | |
| AU2003291103A1 (en) | Pharmaceutical composition | |
| AU2003243150A1 (en) | Resorption-controllable medical implants | |
| EP2295053B8 (en) | Novel 2H-chromen-2-one-3-carboxamides for medical uses | |
| AU2003258298A1 (en) | Medical implants | |
| AU2003250372A1 (en) | Pharmaceutical composition | |
| AU2003245504A1 (en) | Pharmaceutical compositions for drugs having ph-dependentsolubility | |
| AU2002258221A1 (en) | Medicinal composition | |
| AU2003225244A1 (en) | Pharmaceutical compositions for lowering blood glucose and blood cholesterol levels | |
| AU2003281176A1 (en) | Medicinal composition for mitigating blood lipid or lowering blood homocystein | |
| EP1576109A3 (en) | Methods and compositions for categorizing patients | |
| AU2003284460A1 (en) | Medicinal composition | |
| AU2003280799A1 (en) | Medicinal composition | |
| AU2003257814A1 (en) | Medicinal composition for lowering blood lipid level | |
| AU2002354460A1 (en) | Medicinal composition | |
| AU2003201886A1 (en) | Medicinal compositions for improving oral absorption | |
| AU2003280678A1 (en) | Medicinal composition | |
| AU2003235931A1 (en) | Vintoperol-containing medicinal composition for transdermal administration | |
| AU2002354101A1 (en) | Medicinal compositions containing human amnion-origin cells | |
| AU2003284623A1 (en) | Medicinal composition for treating sudden deafness | |
| AU2003219680A1 (en) | Methods and compositions for reducing the development of drug tolerance and/or physical dependence | |
| AU2002304576A1 (en) | Hemi-cannula for tracheotomy patients | |
| AUPS188302A0 (en) | Pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |